10,453 Shares in Danaher Corporation $DHR Bought by Bull Harbor Capital LLC

Bull Harbor Capital LLC bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 1st quarter, Holdings Channel.com reports. The firm bought 10,453 shares of the conglomerate’s stock, valued at approximately $1,982,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Elevated Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter worth about $26,000. Hilton Head Capital Partners LLC bought a new position in shares of Danaher in the 4th quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd lifted its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares during the last quarter. JPL Wealth Management LLC acquired a new stake in Danaher in the 3rd quarter worth approximately $25,000. Finally, Main Street Group LTD bought a new stake in Danaher during the first quarter worth approximately $25,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $196.55 on Thursday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The business’s 50 day moving average is $187.44 and its two-hundred day moving average is $195.95. The company has a market cap of $138.17 billion, a P/E ratio of 34.91, a P/E/G ratio of 2.48 and a beta of 0.79. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.77 earnings per share. On average, equities analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is presently 28.42%.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. JPMorgan Chase & Co. reduced their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Citigroup began coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Royal Bank Of Canada raised their target price on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. Finally, UBS Group dropped their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.